An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein - PubMed (original) (raw)

An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein

T J Tsomides et al. Proc Natl Acad Sci U S A. 1991.

Abstract

CD8+ cytotoxic T lymphocytes recognize cell surface complexes formed by class I major histocompatibility complex (MHC-I) glycoproteins and antigenic peptides. We have identified a peptide nonamer (termed IV9) derived from the human immunodeficiency virus that is over a millionfold more active (at subpicomolar concentrations) than peptide analogues longer or shorter by one or two amino acid residues. Although IV9 does not detectably bind to isolated MHC-I molecules as measured by equilibrium dialysis, we quantitated its specific binding in unaltered form to MHC-I on intact cells. Less than 1% of cell surface MHC-I forms complexes with IV9, which suffices to trigger maximal cytotoxic T-lymphocyte activity. By contrast, a peptide dodecamer that includes the IV9 sequence and is active at micromolar concentrations does not bind to MHC-I on intact cells, raising the possibility that this longer peptide undergoes processing. Using stoichiometrically iodinated IV9 to obviate the ambiguities associated with trace labeling methods, we measured the dissociation kinetics of purified peptide/MHC-I complexes isolated by affinity chromatography and found these complexes to be exceedingly stable (t1/2 = 200-600 hr).

PubMed Disclaimer

Cited by

Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling.
Anikeeva N, Gakamsky D, Schøller J, Sykulev Y. Anikeeva N, et al. PLoS One. 2012;7(8):e41466. doi: 10.1371/journal.pone.0041466. Epub 2012 Aug 3. PLoS One. 2012. PMID: 22870225 Free PMC article.
Extent of MHC Clustering Regulates Selectivity and Effectiveness of T Cell Responses.
Anikeeva N, Fischer NO, Blanchette CD, Sykulev Y. Anikeeva N, et al. J Immunol. 2019 Jan 15;202(2):591-597. doi: 10.4049/jimmunol.1801196. Epub 2018 Dec 12. J Immunol. 2019. PMID: 30541879 Free PMC article.
Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
Cao H, Kanki P, Sankalé JL, Dieng-Sarr A, Mazzara GP, Kalams SA, Korber B, Mboup S, Walker BD. Cao H, et al. J Virol. 1997 Nov;71(11):8615-23. doi: 10.1128/JVI.71.11.8615-8623.1997. J Virol. 1997. PMID: 9343219 Free PMC article.
Introduction of a point mutation into an HLA class I single-chain trimer induces enhancement of CTL priming and antitumor immunity.
Matsui M, Kawano M, Matsushita S, Akatsuka T. Matsui M, et al. Mol Ther Methods Clin Dev. 2014 Jul 2;1:14027. doi: 10.1038/mtm.2014.27. eCollection 2014. Mol Ther Methods Clin Dev. 2014. PMID: 26015969 Free PMC article.
Dendritic cell-based immunotherapy for colon cancer using an HLA-A*0201-restricted cytotoxic T-lymphocyte epitope from tumor-associated antigen 90K.
Hee Lee J, Park MS, Hwang JE, Cho SH, Bae WK, Shim HJ, Kim DE, Chung IJ. Hee Lee J, et al. Cell Mol Immunol. 2013 May;10(3):275-82. doi: 10.1038/cmi.2012.74. Epub 2013 Mar 25. Cell Mol Immunol. 2013. PMID: 23524651 Free PMC article.

References

1. Nature. 1990 Nov 15;348(6298):213-6 - PubMed
1. Eur J Biochem. 1969 Jun;9(3):371-7 - PubMed
1. Nature. 1991 May 23;351(6324):290-6 - PubMed
1. Nature. 1990 Nov 15;348(6298):252-4 - PubMed
1. Nature. 1991 Jul 4;352(6330):67-70 - PubMed

An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein - PubMed (original) (raw)